A Cautionary Note: Botulinum Toxin for Cervical Dystonia Reconstituted in Sterile Water: More Pain, Still Gain
- PMID: 35005078
- PMCID: PMC8721831
- DOI: 10.1002/mdc3.13356
A Cautionary Note: Botulinum Toxin for Cervical Dystonia Reconstituted in Sterile Water: More Pain, Still Gain
Keywords: botulinum toxin; injection site pain; sterile water.
Conflict of interest statement
Dr Koelman reports grants from Ipsen, Allergan, Merz. The other authors declare no conflict of interest.
Similar articles
-
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.Drugs. 2002;62(4):705-22. doi: 10.2165/00003495-200262040-00011. Drugs. 2002. PMID: 11893235 Review.
-
Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.J Formos Med Assoc. 1995 Apr;94(4):189-92. J Formos Med Assoc. 1995. PMID: 7606182 Review.
-
Severity and impact of xerostomia in patients treated with botulinum toxin type b for cervical dystonia: Observations on the quality of life of patients with xerostomia.Curr Ther Res Clin Exp. 2004 Mar;65(2):161-71. doi: 10.1016/S0011-393X(04)90030-6. Curr Ther Res Clin Exp. 2004. PMID: 24936114 Free PMC article.
-
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.Clin Neuropharmacol. 1993 Jun;16(3):205-10. doi: 10.1097/00002826-199306000-00003. Clin Neuropharmacol. 1993. PMID: 8504437
-
A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.Parkinsonism Relat Disord. 2019 Jun;63:195-198. doi: 10.1016/j.parkreldis.2019.02.035. Epub 2019 Feb 25. Parkinsonism Relat Disord. 2019. PMID: 30837195 Clinical Trial.
References
-
- Louca Jounger S, Svedenlöf J, Elenius R, Källkrans C, Scheid E, Ernberg M, Christidis N. Sterile water; a novel and promising human experimental craniofacial muscle pain model. J Oral Rehabil 2021;48(6):654–665. - PubMed
-
- Liu A, Carruthers A, Cohen JL, et al. Recommendations and current practices for the reconstitution and storage of botulinum toxin type A. J Am Acad Dermatol 2012;67(3):373–378. - PubMed
-
- Kranz G, Sycha T, Voller B, Gleiss A, Schnider P, Auff E. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions. Dermatol Surg 2006;32(7):886–890. - PubMed
-
- Eisele KH, Fink K, Vey M, Taylor HV. Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 2011;57(4):555–565. - PubMed
-
- Tsui JKC, Jon Stoessl A, Eisen A, Calne S, Calne DB. Double‐blind study of botulinum toxin in spasmodic torticollis. Lancet 1986;328(8501):245–247. - PubMed
LinkOut - more resources
Full Text Sources